Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient

Nephrology Dialysis Transplantation

Volumn 17, Issue 12, 2002, Pages 2252-2254

  van Zonneveld, Monika ^a   Droogh, Joseph M ^a   Fieren, Marien W J A ^a   Gyssens, Inge C ^a   van Gelder, Teun ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bacteraemia; Immunosuppression; Kidney transplantation; Osteomyelitis; Yershinia pseudotuberculosis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFUROXIME; CIPROFLOXACIN; CREATININE; CYCLOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; FERRITIN; GENTAMICIN; GLUCOSE; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSFERRIN; UREA;

ABDOMINAL SCINTISCANNING; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; FEVER; FOCAL GLOMERULOSCLEROSIS; GRAM NEGATIVE SEPSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MALE; OSTEOMYELITIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECIPIENT; SPLEEN ABSCESS; SPLEEN BIOPSY; YERSINIA PSEUDOTUBERCULOSIS;

ANTI-INFECTIVE AGENTS; BACTEREMIA; CIPROFLOXACIN; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUNG DISEASES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; RETREATMENT; SPLENIC DISEASES; TOMOGRAPHY, X-RAY COMPUTED; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 0036898140     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.12.2252     Document Type: Article

References (10)

1. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353: 1083-1091
2. Schmaldienst S, Hörl WH. Bacterial infections after renal transplantation. Contrib Nephrol 1998; 124: 18-42
3. Butler T. Yersinia species (including plague). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th Edn. Churchill Livingstone, New York 2000; 2406-2413
4. Ljungeberg P, Valtonen M, Harjola VP et al. Report of four cases of Yersinia pseudotuberculosis septicemia and a literature review. Eur J Clin Microbiol Infect Dis 1995; 14: 804-810
5. Rothmell WK, Arguin P, Chan S, Yu A. Yersinia pseudotuberculosis bacteremia and splenic abscess in a patient with non-insulin-dependent diabetes mellitus. West J Med 1999; 170: 110-112
6. Hubbert WT, Petenyl CW, Glasgow LA et al. Yersinia pseudotuberculosis infection in the United States. Am J Trop Med Hyg 1971; 20: 679-684
7. Piroth L, Meyer P, Bielefeld P, Besancenot JF. Yersinia bacteremia and iron overload. Rev Med Interne 1997; 18: 932-938
8. Freland C, Trichereau R, Guenel J, Soulillou JP. Infection inhabituelle chez un transplanté rénal: abcès et septicémie à Yersinia pseudotuberculosis. Presse Med 1977; 6: 1049
9. Kanazawa Y, Ikemura K, Kuramata T. Drug susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis. In: Prpic JK, Davey RB, eds. The Genus Yersinia: Epidemiology, Molecular Biology and Pathogenesis. Karger, Basel: 1987; 127-135
10. Lemaitre BC, Mazigh DA, Scavizzi MR. Failure of β-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection. Antimicrob Agents Chemother 1991; 35: 1785-1790